Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference
Intra-Cellular Therapies(US:ITCI) Newsfilter·2024-08-08 12:00Company Overview - Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on developing and commercializing therapeutics for central nervous system (CNS) disorders [1][3] - The company is founded on Nobel prize-winning research that enhances the understanding of how therapies affect cellular functions [3] Upcoming Event - Sharon Mates, Ph.D., the CEO and Chairman of Intra-Cellular Therapies, is scheduled to present at the Canaccord Genuity 44th Annual Growth Conference on August 13, 2024, at 12:00 p.m. ET in Boston, MA [1] - The live and archived webcast of the presentation will be available under "Events & Presentations" in the Investor Relations section of the company's website [2]